OptiBiotix Health (LSE:OPTI) Interest Expense : £0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2011. Start your Free Trial

What is OptiBiotix Health Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. OptiBiotix Health's interest expense for the six months ended in Jun. 2023 was £ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2023 was £0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. OptiBiotix Health's Operating Income for the six months ended in Jun. 2023 was £ -0.76 Mil. OptiBiotix Health's Interest Expense for the six months ended in Jun. 2023 was £ 0.00 Mil. OptiBiotix Health has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

OptiBiotix Health Interest Expense Historical Data

The historical data trend for OptiBiotix Health's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OptiBiotix Health Interest Expense Chart

OptiBiotix Health Annual Data

Trend

Jul10

Jul12

Nov14

Nov15

Nov16

Nov17

Nov18

Dec20

Dec21

Dec22

Interest Expense

Get a 7-Day Free Trial

-0.01

-0.05

OptiBiotix Health Semi-Annual Data
	Jul12	Jan13	May14	Nov14	May15	Nov15	May16	Nov16	May17	Nov17	May18	Nov18	May19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Interest Expense	Get a 7-Day Free Trial															-0.02	-0.03	-	-	-

OptiBiotix Health Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

OptiBiotix Health (LSE:OPTI) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

OptiBiotix Health's Interest Expense for the six months ended in Jun. 2023 was £0.00 Mil. Its Operating Income for the six months ended in Jun. 2023 was £-0.76 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2023 was £0.00 Mil.

OptiBiotix Health's Interest Coverage for the quarter that ended in Jun. 2023 is calculated as

OptiBiotix Health had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

OptiBiotix Health PLC has no debt.

OptiBiotix Health (LSE:OPTI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OptiBiotix Health PLC (LSE:OPTI) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

OPTI.GB:UK OB3:Germany

Address

Innovation Centre, Innovation Way, Heslington, York, GBR, YO10 5DG

Website

https://www.optibiotix.com

OptiBiotix Health PLC is engaged in the field of healthcare. As a life science company, its prime focus lies in researching the area of biotechnology. Its activities include the identification of microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology, deriving potential health benefits. The company derives majority of the revenue from the sale of Functional Fibres. The company markets its products in the United Kingdom under trademark names such as OptiBiotix, SweetBiotix, and SkinBioTherapeutics.